StonvexLoading…
StonvexStonvexStonvexCore line items from PETS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $136.20M | $95.54M | $51.18M | $226.97M |
Operating Income | $-52.98M | $-42.51M | $-34.13M | $-1.53M |
Net Income | $-53.23M | $-42.67M | $-34.15M | $-6.27M |
EPS (Diluted) | $-2.55 | $-2.05 | $-1.65 | $-0.30 |
Total Assets | $87.97M | $100.30M | $109.84M | $148.70M |
Total Liabilities | $55.20M | $57.24M | $58.29M | $63.57M |
Cash & Equivalents | $26.91M | $36.10M | $41.13M | $54.72M |
Free Cash Flow OCF − CapEx | $-27.55M | $-18.36M | $-13.56M | $-395.00K |
Shares Outstanding | 21.38M | 21.02M | 20.84M | 20.66M |